Related Experiment Video
Updated: May 31, 2026
08:59
Defining Substrate Specificities for Lipase and Phospholipase Candidates
Published on: November 23, 2016
Targeting phosphatidylcholine-specific phospholipase C for atherogenesis therapy
HaiYing Li1, Lu Zhang, DeLing Yin
1Shandong Provincial Key Laboratory of Animal Cells and Developmental Biology, Institute of Developmental Biology, School of Life Science, Shandong University, Jinan 250100, China.
Trends in Cardiovascular Medicine
|July 12, 2011
Summary
Phosphatidylcholine-specific phospholipase C (PC-PLC) drives atherosclerosis progression by causing endothelial dysfunction and inflammation. Blocking PC-PLC offers a promising therapeutic strategy for this major vascular disease.
Area of Science:
- Cardiovascular Research
- Molecular Biology
- Pathology
Background:
- Atherosclerosis is a leading cause of death, characterized by vascular endothelial dysfunction and inflammation.
- Phosphatidylcholine-specific phospholipase C (PC-PLC) is increasingly implicated in endothelial dysfunction and inflammatory pathways.
- Previous research indicates PC-PLC's contribution to atherosclerosis development.
Purpose of the Study:
- To investigate the role of PC-PLC in the progression of atherosclerosis.
- To evaluate the potential of PC-PLC as a therapeutic target for atherosclerosis.
Main Methods:
- The study likely involved in vitro and/or in vivo models to assess PC-PLC activity and its effects on vascular cells.
- Analysis of inflammatory markers and endothelial function in the context of PC-PLC activity.
- Pharmacological inhibition of PC-PLC was explored.
Main Results:
- PC-PLC was confirmed to play a significant role in the progression of atherosclerosis.
- Evidence suggests PC-PLC contributes to endothelial cell dysfunction.
- PC-PLC exhibits proinflammatory properties relevant to vascular disease.
Conclusions:
- PC-PLC is a key mediator in the pathogenesis of atherosclerosis.
- Targeting PC-PLC pharmacologically presents a rational therapeutic approach.
- Inhibition of PC-PLC may offer a novel strategy to combat atherosclerosis.
Related Concept Videos
01:27Synthesis of Phosphatidylcholine in the ER Membrane
The ER synthesizes lipids for building cell membranes and performing cellular functions such as energy storage and signaling. The lipid synthesis machinery embedded in the ER membrane primarily collects all reactants from the cytosol. Following synthesis, the secretory pathway and the ER contact sites distribute these lipids to other cellular organelles. Additionally, the energy-rich triacylglycerides are transported from the ER via lipid droplets.
The major components of all eukaryotic cell...
The major components of all eukaryotic cell...
01:26Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
01:42Phosphoinositides and PIPs
Phosphoinositides are a group of phospholipids containing a glycerol backbone with two fatty acid chains and a phosphate attached to a myoinositol sugar ring. The inositol head group extends into the cytoplasm, where it is modified by adding phosphate groups to form phosphatidylinositol phosphates or PIPs.
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
01:27Peripheral Artery Disease III: Interprofessional Care
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
01:30Atherosclerosis I: Introduction
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...